David C. Mun-Gavin
CIK: 0002078965
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GTBP
GT Biopharma, Inc.
Director
Discretionary Trading P&L
Holdings
About Mun-Gavin David C.
Mun-Gavin David C. (SEC CIK 0002078965) files insider reports with the SEC as Director of GT Biopharma, Inc. (GTBP).
Signal8 holds 2 ownership filings by Mun-Gavin David C. (1 Form 3, 1 Form 4), filed between Jul 30, 2025 and Sep 8, 2025. Those filings report 1 transaction, the latest on Sep 4, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Mun-Gavin David C.'s filings is in SAN FRANCISCO, CA.
Recent filings by Mun-Gavin David C.
- Sep 4, 2025: Grant or award of GTBP derivative securities (Form 4, code A).
Other insiders filing for GT Biopharma, Inc. (GTBP)
- Breen Michael Martin, CEO and Director
- URBAN ALAN LOUIS, Chief Financial Officer
- CASAMENTO CHARLES J, Director
- Kramer Hilary, Director
- Ritter Andrew J, Director